Accessibility StatementSkip Navigation NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Kenvue Inc. (NYSE: KVUE) and its board of directors concerning the proposed acquisition of the company by Kimberly-Clark Corporation (NASDAQ: KMB). Stockholders will receive $3.50 and 0.14625 shares of Kimberly-Clark common stock for each share of Kenvue stock that they hold. The transaction is valued at approximately $48.7 billion and is expected to close in ...

DEADLINE: November 17, 2025 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/cytokinetics-incorporated-loss-submission- form/?id=174892&from=4 Accessibility StatementSkip Navigation NEW YORK, Nov. 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK). Shareholders who purchased shares of CYTK during the class period listed are encouraged t ...

SAN FRANCISCO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The new class action, King v. aTyr Pharma Inc., filed in the U.S. District Court for the Southern District of California on behalf of investors who suffered substantial losses, now seeks to represent all persons and entities who acquired aTyr Pharm ...

LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Brunello Cucinelli S.p.A. (“Brunello Cucinelli” or “the Company”) (OTC Markets: BCUCY) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Brunello Cucinelli is the subject of a report publ ...

针对陶氏公司的集体诉讼核心指控 - 诉讼指控陶氏公司在2025年1月30日至2025年7月23日期间发布了重大虚假和/或误导性陈述[1] - 指控内容包括公司 overstated 其缓解宏观经济和关税相关阻力以及维持支持其丰厚股息所需财务灵活性的能力[1] - 指控公司 understated 上述阻力对其业务和财务状况的负面影响真实范围和严重性 具体涉及竞争和定价压力 全球销售和对公司产品需求的疲软 以及公司全球市场产品供应过剩[1] 集体诉讼程序信息 - 集体诉讼期定义为2025年1月30日至2025年7月23日[1] - 寻求成为首席原告的截止日期为2025年10月28日[2] - 鼓励在该期间内购买陶氏公司股票的股东联系该律师事务所[1]

集体诉讼核心信息 - 诉讼由Gross Law Firm代表在2025年5月7日至2025年8月5日期间购买LifeMD公司股票的股东提起 [1] - 股东登记参与集体诉讼或申请成为首席原告的截止日期为2025年10月27日 [2] - 参与该案件对股东没有成本或义务 [2] 针对LifeMD公司的指控 - 指控称公司在集体诉讼期间发布了重大虚假和/或误导性陈述 [1] - 指控内容包括公司管理层 materially overstated LifeMD的竞争地位 [1] - 指控认为公司在提高2025年业绩指引时是reckless的因其未恰当核算RexMD业务部门不断上升的客户获取成本 [1] - 指控还涉及公司未恰当核算与销售肥胖症治疗药物相关的客户获取成本包括Wegovy和Zepbound [1] - 据称因此公司关于其业务运营和前景的陈述在所有相关时间均存在重大虚假和误导性和/或缺乏合理依据 [1]

法律诉讼与和解方案 - FAT Brands及其股东提出一项1000万美元的联合和解方案 以解决两起衍生诉讼[1] - 诉讼指控公司CEO Andy Wiederhorn及其关联方进行自我交易和滥用资金[1] - 根据和解协议 被告将向公司支付1000万美元现金 并转移20万股已剥离的Twin Hospitality Group股票给FAT Brands[1] 诉讼指控内容 - 第一起诉讼Harris I指控Wiederhorn通过内幕贷款从公司获取数千万美元 并在其控股公司与FAT Brands合并时免除自身债务[1] - 第二起诉讼Harris II指控Wiederhorn为自己创建了一类超级投票权股票 使其获得公司股份的永久控制权[1] 公司治理改革 - 作为和解的一部分 公司将采纳公司治理改革措施[1] - 改革包括聘请经验丰富的首席财务官 财务总监和总法律顾问[1] - 改革还包括设立一个审计委员会 在独立法律顾问的参与下审查财务交易[1] 其他相关法律事务 - 该和解方案与2024年6月前投资者提起的另一宗指控证券法违规的诉讼是分开的独立法律事项[2] - Harris诉讼与美国司法部和证券交易委员会的调查相关 司法部已于2025年7月撤销指控 证交会的民事指控仍在上诉中[2] 和解后续步骤 - 如果法院批准和解 Harris诉讼将立即终止 Wiederhorn及其关联方将免受就同一事项再次被起诉[3] - 和解听证会定于12月举行[3]

法律调查事件 - 律师事务所Bragar Eagel & Squire, P C正在对James Hardie Industries plc展开调查，涉及该公司可能违反联邦证券法或其他非法商业行为 [1] 公司财务表现 - James Hardie公布截至2025年6月30日的2026财年第一季度业绩，其中第一季度利润同比下降29% [5] - 公司预计2026财年全年收益将低于市场预期，并将原因归咎于高昂的借贷成本 [5] 市场股价反应 - 在2025年8月19日发布财报后，James Hardie的美国存托凭证价格在8月20日下跌9.79美元，跌幅达34.44%，收于每股18.64美元 [5]

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA). Shareholders who purchased shares of SVRA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/savara-inc-loss-submission-form/?id=172046&from=3 CLASS PERIOD: March 4, 2024 to May 2 ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fortinet, Inc. (NASDAQ: FTNT). Shareholders who purchased shares of FTNT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/fortinet-inc-loss-submission-form/?id=172040&fro ...